Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

ClinicalTrials.gov ID: NCT07145229

Public ClinicalTrials.gov record NCT07145229. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects With an Acute Gout Flare

Study identification

NCT ID
NCT07145229
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Atom Therapeutics Co., Ltd
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • ABP-745 Dose A Drug
  • ABP-745 Dose B Drug
  • Colchicine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2025
Primary completion
Apr 30, 2026
Completion
May 31, 2026
Last update posted
Dec 7, 2025

2025 – 2026

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Onyx Clinical Research Peoria Arizona 61636 Recruiting
Exinia Research La Mesa California 91942 Recruiting
Evergreen Clinical Trial Norcross Georgia 30003 Not yet recruiting
Bioluminux Clinical Research Naperville Illinois 60540 Recruiting
Exinia Research Des Moines Iowa 50308 Recruiting
Northshore Research Associates Alexandria Louisiana 71303 Recruiting
DelRicht Research Baton Rouge Louisiana 70769 Recruiting
DelRicht Research New Orleans Louisiana 70115 Recruiting
Interphase Clinical Trials Lutherville Maryland 21093 Recruiting
DelRicht Research Gulfport Gulfport Mississippi 39501 Recruiting
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87176 Recruiting
West Clinical Research Morehead City North Carolina 28557 Not yet recruiting
DelRicht Research Tulsa Oklahoma 74133 Recruiting
Premier Family Physicians Austin Texas 78734 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07145229, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07145229 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →